PD-L1 is another key molecule in the tumor immunity, which binds to PD-1 on the surface of CD8+ T cells, inhibiting the proliferation, activation and cytokine secretion of CD8+ T cells (25). The gene discussed is CD8A; the disease is neoplasm.